Douglas Samuel

Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial

Sudarshan Paramsothy, Michael A. Kamm, Nadeem O. Kaakoush et al. · The Lancet · 2017 · 1.3K citations

Life Sciences, Immunology, Microbiome Research +14

Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

Sudarshan Paramsothy, Shaun Nielsen, Michael A. Kamm et al. · Gastroenterology · 2018 · 527 citations · Full text

Life Sciences, Immunology, Microbiology +17

Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn's Disease After Surgery

Emily K. Wright, Michael A. Kamm, Peter De Cruz et al. · Gastroenterology · 2015 · 281 citations

Medicine, Clinical Sciences, Surgery +8

Donor Recruitment for Fecal Microbiota Transplantation

Sudarshan Paramsothy, Thomas J. Borody, Enmoore Lin et al. · Inflammatory Bowel Diseases · 2015 · 149 citations · Full text

Medicine, Microbiology, Surgery +12

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15